Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 215

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling

Open access
Mohamed, Eslam, Sierra, Rosa A., Trillo-Tinoco, Jimena, Cao, Yu, Innamarato, Patrick, Payne, Kyle K., de Mingo Pulido, Alvaro, Mandula, Jessica, Zhang, Shuzhong, Thevenot, Paul, Biswas, Subir, Abdalla, Sarah K., Costich, Tara Lee, Hänggi, Kay, Anadon, Carmen M., Flores, Elsa R., Haura, Eric B., Mehrotra, Shikhar, Pilon-Thomas, Shari, Ruffell, Brian, Munn, David H., Cubillos-Ruiz, Juan R., Conejo-Garcia, Jose R., Rodriguez, Paulo C. · 2020 · Immunity

Abstract

Summary The primary mechanisms supporting the immunoregulatory polarization of myeloid cells upon infiltration into tumors remain largely unexplored. Elucidation of these signals could enable better strategies to restore protective anti-tumor immunity. Here, we investigated the role of the intrinsic activation of the PKR-like endoplasmic-reticulum (ER) kinase (PERK) in the immunoinhibitory actions of tumor-associated Myeloid-derived suppressor cells (MDSC). PERK signaling increased in tumor-MDSC, and its deletion, transformed MDSC into myeloid cells that activated anti-tumor CD8+ T-cell immunity. Tumor-MDSC lacking PERK exhibited disrupted NRF2-driven anti-oxidant capacity and impaired mitochondrial respiratory homeostasis. Moreover, reduced-NRF2 signaling in PERK-deficient MDSC elicited cytosolic mitochondrial-DNA elevation, and consequently, STING-dependent expression of anti-tumor Type-I Interferon. Re-activation of NRF2 signaling, conditional deletion of STING, or blockade of Type-I interferon receptor-I restored immunoinhibitory potential of PERK-ablated MDSC. Our findings demonstrate the pivotal role of PERK in tumor-MDSC functionality and unveil strategies to reprogram immunosuppressive myelopoiesis in tumors to boost cancer immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2020.03.004

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 215

Metadata

Authors
Mohamed, E., Sierra, R. A., Trillo-Tinoco, J., Cao, Y., Innamarato, P., Payne, K. K., de Mingo Pulido, A., Mandula, J., Zhang, S., Thevenot, P., Biswas, S., Abdalla, S. K., Costich, T. L., Hänggi, K., Anadon, C. M., Flores, E. R., Haura, E. B., Mehrotra, S., Pilon-Thomas, S., Ruffell, B., Munn, D. H., Cubillos-Ruiz, J. R., Conejo-Garcia, J. R., & Rodriguez, P. C.
Venue
Immunity
Publisher
Elsevier BV
Published
2020-04
Volume
52
Issue
4
Pages
668-682.e7
ISSN
1074-7613 (ISSN-L)
OpenAlex
W3015575990
Cited by
215
References
16
FWCI
7.23
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.